WA biotech Orthocell has announced a promising new use case for its Remplir nerve regeneration product, this time in reducing post-surgical complications in prostate cancer sufferers.

WA biotech Orthocell has announced a promising new use case for its Remplir nerve regeneration product, this time in reducing post-surgical complications in prostate cancer sufferers.